Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little is known about how MSCs interact with the

NIAID Data Ecosystem70

Cell And Gene Therapy Thawing Equipment Market

细胞治疗

基因治疗

The Cell And Gene Therapy Thawing Equipment market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competit

IMR REPORTS30

Cell Therapy Processing Market Size to Flourish at a CAGR of 27.60% by 2031

细胞治疗

市场分析

The global cell therapy processing market size was valued at USD 4,493.37 million in 2022. It is estimated to reach USD 40,292.87 million by 2031, growing at a CAGR of 27.60% during the forecast perio

straitsresearch.com2025-03-26 更新100

Baseline parameters.

成本效益分析

细胞治疗

Objectives Current osteoarthritis treatments are designed to reduce pain and improve mobility instead of promoting the regeneration of cartilage. Cell-based therapies are being developed for the treat

NIAID Data Ecosystem40